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Background: Klebsiella pneumoniae is a leading cause of severe hospital-acquired respiratory tract infections and
death but little is known regarding the modulation of respiratory dendritic cell (DC) subsets. Plasmacytoid DC (pDC)
are specialized type 1 interferon producing cells and considered to be classical mediators of antiviral immunity.
Method: By using multiparameter flow cytometry analysis we have analysed the modulation of respiratory DC
subsets after intratracheal Klebsiella pneumonia infection.
Results: Data indicate that pDCs and MoDC were markedly elevated in the post acute pneumonia phase when
compared to mock-infected controls. Analysis of draining mediastinal lymph nodes revealed a rapid increase of
activated CD103+ DC, CD11b+ DC and MoDC within 48 h post infection. Lung pDC identification during bacterial
pneumonia was confirmed by extended phenotyping for 120G8, mPDCA-1 and Siglec-H expression and by
demonstration of high Interferon-alpha producing capacity after cell sorting. Cytokine expression analysis of
ex vivo-sorted respiratory DC subpopulations from infected animals revealed elevated Interferon-alpha in pDC,
elevated IFN-gamma, IL-4 and IL-13 in CD103+ DC and IL-19 and IL-12p35 in CD11b+ DC subsets in comparison to
CD11c+ MHC-class IIlow cells indicating distinct functional roles. Antigen-specific naive CD4+ T cell stimulatory
capacity of purified respiratory DC subsets was analysed in a model system with purified ovalbumin T cell receptor
transgenic naive CD4+ responder T cells and respiratory DC subsets, pulsed with ovalbumin and matured with
Klebsiella pneumoniae lysate. CD103+ DC and CD11b+ DC subsets represented the most potent naive CD4+ T
helper cell activators.
Conclusion: These results provide novel insight into the activation of respiratory DC subsets during Klebsiella
pneumonia infection. The detection of increased respiratory pDC numbers in bacterial pneumonia may indicate
possible novel pDC functions with respect to lung repair and regeneration.
Keywords: Klebsiella pneumonia, Pneumonia, Plasmacytoid dendritic cellsIntroduction
Klebsiella spp. are gram-negative bacteria and important
opportunistic pathogens causing life-threatening nosoco-
mial infections [1,2]. Typical clinical presentations of
Klebsiella pneumonia are nosocomial respiratory tract
infections, urinary tract infections, infections of the
bloodstream and premature infant intensive care unit in-
fections [1,3-6]. Multidrug resistant Klebsiella pneumo-
nia strains are becoming an increasingly relevant* Correspondence: Holger.Hackstein@immunologie.med.uni-giessen.de
1Institute for Clinical Immunology and Transfusion Medicine,
Justus-Liebig-University Giessen, Member of the German Center for Lung
Research (DZL), Langhansstr. 7, D-35392, Giessen, Germany
Full list of author information is available at the end of the article
© 2013 Hackstein et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormedical problem worldwide with limited clinical treat-
ment options [7-11]. Therefore, there is a medical need
for the development of novel therapeutic strategies in
addition to classical antibiotic therapies. However, des-
pite the clinical significance of Klebsiella pneumonia, lit-
tle is known regarding the modulation of respiratory
dendritic cells (DC) subsets during lower respiratory
tract infection with Klebsiella spp.
DC are central instigators of innate and adaptive im-
munity regulating both inflammation and activation of
antigen-specific lymphocytes [12-14]. Based on the ex-
pression of different surface markers respiratory DC can
be separated in at least four subsets, plasmacytoid DCral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(MoDc) [15-19]. PDC represent the most potent pro-
ducers of Interferon-alpha and therefore play critical roles
in antiviral immunity [20-23]. Additionally, it has been
reported that pDC sense skin injury and promote wound
healing through type I interferon suggesting a novel role
for these professional antigen presenting cells [24].
Respiratory CD103+ DC have been reported to be in-
volved in the development of airway hyperresponsiveness
and to play important roles in naive CD8+ T cell activation
and antiviral respiratory immunity [25,26]. With respect
to bacterial respiratory tract infections, CD103+ DC have
been shown to play a key role for α-Galactosylceramide
-mediated protection against lethal Streptococcus pneu-
monia infection [27]. Together with CD11bhi DC and
MoDC, CD103+ DC have been suggested to represent the
major migratory DC subsets promoting naive CD4+ and
CD8+ T cell activation in the draining lymph nodes
[15,26,28-30].
We have used multicolor flow cytometry to dissect
and quantitate respiratory DC subsets during murine
Klebsiella pneumonia. Additionally, respiratory DC sub-
sets were purified by cell sorting from Klebsiella-infected
animals and analysed for cytokine mRNA expression.
The functional CD4+ naive T cell stimulatory capacity of
purified respiratory DC subsets was determined in vitro
after Klebsiella pneumonia lysate stimulation of
ovalbumin-pulsed DCs and ovalbumin (OVA) T-cell re-
ceptor (TCR)-transgenic naive CD4+ responder T cells.
Materials and methods
Mice and treatment protocol
Specific-pathogen-free C57BL/6 (C57BL/6NCrl) and OVA
TCR transgenic C57BL/6-Tg(TcraTcrb)425Cbn/J mice
(18-21 g) were purchased from Charles River, Sulzfeld,
Germany and maintained under specific-pathogen-free
conditions. The transgenic mice express the TCR that
pairs with the CD4 coreceptor and is specific for chicken
OVA 323–339 in the context of MHC-class-II (I-Ab).
Wild-type mice were infected intratracheally with Klebsi-
ella pneumonia serotype 2 (1 × 104 in sterile PBS in 50 μl)
as described [31] and analysed at the indicated timepoints.
Mock-infected controls were treated identical but received
sterile NaCl instead of Klebsiella pneumonia. Analyses
were performed after approval of the regional authority
board City of Giessen (#71/2009 and # A25/2009).
Lung and mediastinal lymph node preparation
Lung single cell suspension were prepared after enzym-
atic digestion as described in detail elsewhere [16,17].
Absolute respiratory cell counts were enumerated with
the trucount method (BD Biosciences, Germany) as de-
scribed [16,17]. Trucount tubes contain a known num-
ber of fluorescent beads allowing the flow cytometersoftware to calculate absolute cell counts. Single cell sus-
pension from mediastinal lymph nodes (MLN) were
minced and digested in RPMI 1640/10% FCS (PAA la-
boratories, Germany) with 10 U/ml DNase and 1 mg/ml
Collagenase A (Roche, Germany) for 30 min at 37 C,
resuspended with a 20 G 1 ½ canule (0.9 × 40 mm, BD,
Germany), mashed through a 70 μm cell strainer and
washed two times with HBSS (7 min, 400 g; PAA labora-
tories, Germany).
Flow cytometry and fluorescent activated cell sorting
Cellular phenotyping was performed on a BD CantoII flow
cytometer and fluorescent activated cell sorting was
performed on a BD ARIA3 cell sorter (Becton Dickinson,
San Jose, CA, USA). The following fluorochrome-labelled
monoclonal antibodies conjugated to FITC, PE, PeCy7,
PerCPCy5.5, APC, APC-Cy7, Pacific Blue and appropriate
isotype controls were used for surface staining according
to the manufacturer’s instructions: CD11b, CD11c, CD45,
CD64, CD86, CD103, CD274, I-Ab, GR-1, Ly-6G, F4/80,
NK1.1, FcεRIα (MAR-1), Siglec-H, Siglec-F (BD Biosci-
ences, Germany), mPDCA-1 (MiltenyiBiotec, Germany),
120G8 (Dendritics, France). Surface mAb or isotype stain-
ing time was 30 min on ice and cells were washed with
staining buffer (1 × HBSS, PAA, Germany) at 400 g, 5 min,
room temperature (RT) before analysis. The number of
acquired events was ≥ 500,000 after surface stainings.
Highly purified naive OVA TCR transgenic CD4+ T
cells were prepared from spleen cell suspensions. First,
MHC-class-II and CD19 positive cells were depleted
with magnetic-beads (MiltenyiBiotec) on an Auto-
MACS magnetic-bead sorter (MiltenyiBiotec) and subse-
quently naive CD4+ T cells were sorted on the ARIA3
sorter after surface staining with a lineage cocktail
(CD8a, CD25, CD11b, CD11c, CD45R, CD49b) and
CD62L mAbs to identify naive T cells . The post sort
purity of CD4+ CD62L+CD44dim cells was >98%. Re-
spiratory DC subsets were sorted on the ARIA3 cell
sorter (purity >98%; Additional file 1: Figure S1). Viabil-
ity of cells was > 90% as indicated by sytox blue (Life
Technologies, Germany) staining. All mabs were ordered
from Biolegend, Germany unless indicated otherwise.
Gating strategy for respiratory leukocyte subset
discrimination
The gating strategy for the respiratory subsets, including
respiratory DC subsets has been described recently in de-
tail [17,19]. Briefly, respiratory leukocytes were identified
by CD45 expression. Out of the CD45+ cells, neutrophils
were identified by GR1brightCD11bbright expression. Subse-
quently, out of the neutrophil negative fraction, macro-
phages were identified as SiglecF++F4/80+ double positive
cells. Respiratory dendritic cells (DC) were identified
according to CD11c+Siglec-Fneg NK1.1neg expression to
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further dissected into pDC (120 g8+ CD11bneg), CD103
DC (CD103+ CD11bneg) and CD11b DC (CD11b+
CD103neg). MoDC were discriminated from CD11b DC
based on CD64 and MAR1 expression as described re-
cently [19]. In MLN, cells were additionally stained for
CCR7 to identify migrating CD103 DC, CD11b DC and
MoDC (Additional file 2: Figure S2). Fluorescence minus
one (FMO) isotype controls were used regularly for proper
identification of marker positive subsets.
Naive CD4+ T cell proliferation assay
Purified DC subsets (1 × 104/well) were incubated in cul-
ture medium (±100 μg/ml endotoxin-free OVA; Hyglos,
Germany) with carboxyfluorescein diacetate succinimidyl
ester (CFSE) labeled purified naive CD4+ OVA TCR
transgenic responder cells (1 × 105/well) in 96 well
round bottom wells (Greiner, Germany) for five days.
Klebsiella pneumonia lysate was prepared as described
[16] and added at a concentration of 10 ul/ml (1:100)
4 h after OVA for DC maturation. DC maturation with
different Klebsiella pneumonia lysate dilutions (1:10–
1:500) was controlled by flow cytometry analysis of
CD86 and MHC-class II expression on respiratory
DC (Additional file 3: Figure S3). Culture medium
consisted of RPMI 1640 with L-glutamine (PAA Labora-
tories), penicillin/streptomycin (PAN Biotech), sodium-
pyruvate (Gibco), nonessential aminoacids (Sigma),
Hepes buffer (Gibco), and 10% heat inactivated FCS
(PAA Laboratories). CFSE labeling concentration was
1 μM and was performed according to the manufacturer
instructions (Vybrant CFDA-Cell Tracer kit, Molecular
probes, Eugene, USA). Positive controls consisted of
in vitro bone-marrow-derived DC (expanded as de-
scribed [32]) with OVA and responder cells. Negative
controls consisted of responder cells cultured with OVA
in the absence of stimulator cells and responder cells
cultured with stimulator cells in the absence of ovalbu-
min. Proliferation was quantitated by measurement of
CFSE-dilution in responder cells by flow cytometry as
described [33]. Positive bone-marrow-derived control
DC pulsed with OVA induced naive CD4+ responder
proliferation rates of >80%. Proliferation rates in nega-
tive controls were < 5%.
IFN-α induction and quantitation
IFN-α production was stimulated with CpG ODN2216
(6 μg/ml) in sorted cell subsets after overnight culture in
RPMI 1640 with 10% FCS (PAA Laboratories). IFN-α was
quantitated in cellular supernatants on the FACS CantoII
flow cytometer in parallel to recombinant cytokine stan-
dards by using the cytometric bead assay technology
according to the manufacturer instructions (Flowcytomix,
eBioscience, Germany).Cytokine mRNA quantification
Cytokine mRNA expression was determined in sorted
respiratory DC subsets from Klebsiella-infected ani-
mals by quantitative RT-PCR on an ABI TaqMan Step-
One plus real time PCR system (Applied Biosystems,
Germany) with the RT2 profiler PCR assay (Qiagen,
Germany). RNA was isolated with RNeasy Mini Kit
(Qiagen) and transcribed into cDNA with the RT2 Pre-
amp cDNA Synthesis Kit (Qiagen) according to the
manufacturer instructions.
Statistical analyses
The significance of differences between groups were
analysed by one-way ANOVA and Tukey post-test for
multiple comparisons. A p-value < 0.05 was considered
significant. Statistical analyses were performed with
Prism 5.02 software (Graphpad software, Inc., USA).
Results
Respiratory dendritic cell subsets and Klebsiella
pneumonia infection
By using multiparameter flow cytometry we analysed ab-
solute and relative changes of major respiratory leukocyte
populations including neutrophils, macrophages and DC
during acute (48 h p.i.) and post acute (d5 p.i.) respiratory
Klebsiella pneumonia infection (Figure 1A). Total DC
were further dissected by flow cytometry into four major
subsets, MoDC, CD11b+ DC, CD103+ DC and pDC and
relative DC subset frequencies and absolute DC subset
numbers were calculated (Figure 1B,C; Figure 2). Results
indicated that total respiratory DCs in general were in-
creased both at 48 h p.i and d5 p.i. but the dissection of
DC subsets revealed different patterns for each subpopula-
tion (Figure 1B,C). Early after infection (48 h p.i.), relative
CD103+ DC numbers were significantly decreased in ac-
cordance with their reported function to rapidly transport
antigen to regional lymph nodes [34]. Unexpectedly, with
respect to pDC representing the rarest subset, we found a
marked relative and absolute elevation of respiratory pDC
numbers in the post acute phase of Klebsiella pneumonia
(d5 p.i.) when compared to mock-infected controls (p <
0.01; Figure 1B,C). Additionally, absolute numbers of re-
spiratory CD11b+ DC and MoDC were markedly in-
creased at 48 h and day 5 p.i. (Figure 1C). The massive
leukocyte subset changes detected by flow cytometry cor-
related well with histopathology exhibiting extensive cellu-
lar infiltrates and cellular necrosis indicating severe
bacterial pneumonia (Figure 3).
Confirmation of functional respiratory pDC during
Klebsiella pneumonia infection by extended phenotyping
and cell sorting
Given the fact, that Klebsielle pneumonia infection in-
duced major respiratory inflammation we discussed the
Figure 1 Dissection of respiratory leukocyte and DC subsets (MoDC, CD11bhi DC, CD103+ DC, pDC) during Klebsiella pneumonia
infection. Respiratory leukocyte subsets were dissected by flow cytometry as described in Materials and methods (A-C). Relative frequencies and
absolute numbers of respiratory DC subsets were quantitated at indicated timepoints and compared to mock-infected control animals (B, C).
Mean ± SEM; n≥ 4; *p < 0.05; **p < 0.01; ***p < 0.001 versus mock-infected controls.
Hackstein et al. Respiratory Research 2013, 14:91 Page 4 of 11
http://respiratory-research.com/content/14/1/91possibility that pDC identification by flow cytometry
might have been confounded by unspecific surface
marker upregulation due to the inflammatory process.
Accordingly, we extended pDC surface marker ana-
lysis on Klebsiella-infected animals (d5 p.i.) and in-
cluded Siglec-H and mPDCA-1 mAb surface staining
(Figure 4A). These experiments confirmed expression
of Siglec-H and mPDCA-1 on respiratory pDC during
Klebsiella pneumonia. Additionally, in order to use
an independent functional method we sorted lung
120G8+ CD11b- CD11c+ CD45+ putative respiratory
pDC (d5 p.i.) and tested their capacity to produce
IFN-α. These experiments confirmed high IFN-α pro-
ducing capacity in respiratory pDC from Klebsiella-
infected animals in comparison to non-pDC control
fractions (Figure 4B). These data demonstrated that
the immunophenotypically identified pDC during bac-
terial pneumonia, represented viable and functional
respiratory pDC.Distinct cytokine expression of purified respiratory DC
subsets during Klebsiella pneumonia infection
To determine the cytokine expression of respiratory DC
subsets during Klebsiella pneumonia we sorted pDC,
CD103+ DC, CD11b+ DC and CD11c+ MHC-class IIlow
cells from Klebsiella-infected animals (d5 p.i.) to high
purity (>98%) and analysed mRNA expression by quanti-
tative real time RT-PCR. Controls included genomic
DNA controls, reverse transcriptase controls and posi-
tive PCR controls. Relative cytokine expression of pDC,
CD103+ DC and CD11b+ DC in comparison to CD11c+
MHC-class IIlow cells was calculated by the 2(−ΔΔ CT)
method to indicate differences between the subsets
(Figure 5). CD11c+ MHC-class IIlow cells were selected
as common reference because we wanted to display rela-
tive cytokine expression differences in-between pDC,
CD103+ DC and CD11b+ DC. Respiratory pDC
exhibited elevated IFN-α expression indicating activation
during bacterial pneumonia. In contrast, CD103+ DC
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Figure 2 Respiratory DC subsets during Klebsiella pneumonia infection. Dotplot staining and gating of respiratory DC subsets (CD103+ DC,
CD11b+ DC, MoDC, pDC) in Klebsiella-infected animals and mock-infected controls. Fluorescence minus one (FMO) isotype control for proper
identification of CD64+ MoDC.
Figure 3 Significant lung pathology in Klebsiella pneumonia
infected animals. Histopathology of mouse lungs two (upper row)
and five days (bottom row) after mock (left column) and K.
pneumoniae (right column) infection: No changes were present in
mock infected mice. In contrast, extensive interstitial infiltration by
predominantly neutrophils and macrophages was present at two
days after infection of mice with K. pneumoniae. After five days,
additional, predominantly perivascular, lymphocytic infiltrates
were seen. Hematoxylin & Eosin stained lung sections
at 200 ×magnification.
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whereas CD11b DC showed elevated expression of IL-
12p35 and IL-19 in comparison to CD11c+ MHC-class
IIlow cells.
Different modulation of MHC class II, CD86 and CD274
expression on respiratory DC subsets during acute
Klebsiella pneumonia infection
Expression of MHC-class II, CD86 and CD274 represent
functionally important molecules of antigen presenting
cells to regulate CD4+ T responder cell activation. Ac-
cordingly, we quantitated MHC-class II, CD86 and
CD274 surface expression on total respiratory DC and
DC subsets to determine the modulation during acute
and post-acute respiratory Klebsiella pneumonia infec-
tion (Figure 6A,B). Results demonstrated that at 48 h
p.i. and at d5 p.i. respiratory MoDC and to a lesser ex-
tent CD11b+ DC from Klebsiella pneumonia-infected
animals exhibited reduced MHC-class II expression. In
contrast, costimulatory CD86 expression was markedly
increased at 48 h p.i. on respiratory CD103+ DC and
CD11b+ DC of infected animals when compared to
mock-infected-controls. pDC and MoDC did not exhibit
major CD86 expression changes at 48 h p.i. Moreover,
MoDC exhibited at d5 p.i. reduced CD86 expression
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Figure 4 Confirmation of respiratory pDC identity during Klebsiella infection (d5 p.i.) by extended phenotyping and cell sorting.
Identity of pDC during Klebsiella pneumonia was confirmed by additional phenotyping of CD11c + 120 g8+ CD11bneg cells for mPDCA-1 and
Siglec-H in parallel with isotype controls (A). Functional ability of respiratory pDC from Klebsiella infected animals to produce IFN-alpha was
confirmed by cell sorting and CPG ODN stimulation in comparison to control populations (B). Respiratory pDC during Klebsiella pneumonia are
CD11bneg 120G8+ Siglec-H+ mPDCA-1+ cells (A, B) and exhibit the capacity to produce large amounts of IFN-α (B). Mean ± SEM; n≥ 3.
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arrived DC. The immunoregulatory molecule CD274
was most markedly induced on CD11b+ DC and MoDC
both at 48 h p.i. and d5 p.i. whereas expression on
CD103+ DC and pDC was less affected. These results in-
dicated, that respiratory DC subsets exhibited major het-
erogeneity with respect to MHC-class II, CD86 and
CD274 expression during respiratory Klebsiella infection
suggesting different functional capacity to activate re-
sponder T cells. These differences would have been
masked, if respiratory DC were analysed as a singleFigure 5 Relative mRNA cytokine expression of respiratory CD11b+ D
Semi-quantitative mRNA cytokine expression was analysed by real time RT-
fold regulation in relation to MHC-IIlow CD11c+ cells; n≥ 3.CD11c+ Siglec Fneg MHC-II+ population without subset
discrimination.
Klebsiella pneumoniae-activated respiratory DC subsets
exhibit different naive CD4+ T cell stimulatory capacity
In order to determine the naive CD4+ T cell stimulatory
capacity of purified respiratory DC subsets activated by
Klebsiella pneumonia we used an in vitro model system
with CFSE-labelled OVA TCR transgenic CD4+ T helper
cells as antigen-specific responder cells. Stimulatory re-
spiratory DC subsets were sorted to high purity (>98% forC, CD103+ DC, pDC from Klebsiella pneumoniae-infected animals.
PCR in sorted respiratory DC subsets from d5-infected animals. Mean
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Figure 6 Respiratory DC-subset specific expression of MHC-class II, CD86 and CD274 at different timepoints during acute Klebsiella
pneumonia infection. Surface MHC-class II, CD86 and CD274 on total respiratory DC (DC) and DC subsets (pDC, CD103+ DC, MoDC, CD11b+ DC)
were analyzed by flow cytometry during acute and post-acute Klebsiella pneumonia (Kp) infection (48 h and d5 p.i.) and compared to mock-
infected control (ctr) animals (A, B). MFI is median fluorescence intensity; mean ± SEM; n ≥ 3; *p < 0.05; **p < 0.01; ***p < 0.001 versus mock-
infected controls (A-B).
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matured with Klebsiella pneumonia lysate. Additional con-
trols included sorted respiratory macrophages and
granulocytes and in vitro bone-marrow-derived DC with-
out OVA (negative control). Untouched naive CD4+ TCR
transgenic responder cells were magnetic-bead sorted and
the phenotype after sorting was controlled by surface
CD4, CD62L and CD44 staining (purity >98%). Results
indicated that Klebsiella pneumonia-activated CD103+
DC and CD11b+ DC subsets represented the most effi-
cient stimulators of purified naive CD4 T responder cells
(Figure 7; mean proliferation rates 95% and 64%, respect-
ively). In contrast, Klebsiella pneumonia-activated pDC
and CD11c+ MHC-class IIlow cells, as well as granulocytes
and macrophages induced no or only minor naive CD4 T
cell proliferation (< 5%). Interestingly, sorted DC subsets
that were not activated with Klebsiella pneumonia induced
comparable CD4+ T cell proliferation indicating that Kleb-
siella may induce both activatory and inhibitory effects on
DC. Control experiments with cultures of DC + CD4+ T
cells without OVA and CD4+ T cells + OVA without
DC showed no responder cell proliferation and confirmed
the antigen-specificity of the assay (Figure 7A,B). Naïve
CD4+ T cell stimulatory capacity of purified, Klebsiella
activated respiratory DC subsets correlated closely with
MHC-class II and CD86 expression of respiratory DCsubsets from Klebsiella-infected animals (Figure 7) under-
lining the functional importance of MHC-class II and
CD86 expression. Overall, these results indicated marked
differences of Klebsiella-activated respiratory DC subsets
to activate naïve CD4+ T cells.
Rapid accumulation of activated CD103+ DC, CD11b+ DC
and MoDC in the MLN
Analysis of DC subset changes in the draining MLN re-
vealed a marked increase of relative and absolute CCR7+
CD103+DC, CD11b+ DC and MoDC numbers within 48 h
p.i. whereas absolute pDC numbers were elevated on D5
p.i. (Figure 8A,B). Phenotypic analysis of activatory CD86
expression indicated significant upregulation on CD103+
DC and CD11b+ DC in contrast to pDC and MoDC
(Figure 8 C). Interestingly, MHC-class II expression was
impaired to different extent on all DC subsets in compar-
ison to mock-infected controls again suggesting that
Klebsiella pneumonia infection may induce both activatory
and inhibitory effects on antigen presenting cells.
Discussion
Klebsiella pneumoniae is a frequent multidrug-resistant
emerging pathogen playing an increasingly important
role in severe nosocomial infections [7,8,10,11]. DC are
central regulators of innate and adaptive immunity against
Figure 7 Different capacity of purified Klebsiella pneumoniae-stimulated respiratory DC subsets to activate OVA TCR-transgenic naive
CD4+ responder T cells in a CFSE-dilution assay. Respiratory DC subsets were sorted to high purity (>98%), pulsed with the model antigen
OVA and matured with Klebsiella pneumoniae lysate (Kp). Naïve CD4+ responder T cells were sorted from OVA TCR transgenic animals and
labeled with CFSE. Negative controls included DC without Klebsiella lysate (control), responder T cells cultured without DC (no DC) and DC-T cell
co-cultures without OVA (no OVA). Proliferation was quantitated by CFSE-dilution of responder T cells (A,B). Mean ± SEM; n ≥ 3.
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developmental pathways, surface markers and tissue local-
izations, DC can be divided into distinct subsets exhibiting
specific functions [38]. By using multiparameter flow cy-
tometry and cell sorting we have determined the number
and activation of respiratory DC subsets during experi-
mental Klebsiella pneumoniae infection.
Subset-specific respiratory DC quantification of Klebsiella-
infected animals showed that the rare pDC population were
markedly elevated in the post acute disease phase. We
confirmed the identity of functional respiratory pDC
during bacterial pneumonia by extended phenotyping
and demonstration of large IFN-alpha production
capacity after cell sorting. Moreover, elevated IFN-
alpha mRNA expression was demonstrated in puri-
fied respiratory pDC sorted from Klebsiella-infectedanimals. Unexpectedly, cytokine mRNA analysis indi-
cated IL-4 and IL-13 expression in CD103 DC and IL-
19 expression in CD11b DC. Due to the rather low
cytokine mRNA expression, marked pulmonary inflam-
mation and the technical possibility of contaminating
innate lymphoid cells, further detailed studies using
combinations of different methods are required to dis-
sect the cytokine producing capacity of respiratory DC
subsets during gramnegative bacterial pneumonia.
The accumulation of functional respiratory pDC dur-
ing bacterial pneumonia has to the best of our know-
ledge not been reported so far and raises the question
regarding potential novel functions of pDC in bacterial
pneumonia. Respiratory pDC may play a role in tissue
repair. Gregorio et al. recently reported, that pDC accu-
mulate in large numbers in injured skin areas and express
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Figure 8 Quantitative and phenotypic analysis of DC subsets in the MLN at different time points during Klebsiella pneumonia
infection. Relative and absolute CD103+ DC, CD11b+ DC, MoDC and pDC subset numbers (A, B) and phenotypic markers (C) were analyzed at
indicated time points in the MLN and compared to mock-infected controls by flow cytometry as described in Materials and methods. Mean ±
SEM; n ≥ 3; *p < 0.05; **p < 0.01; ***p < 0.001 versus mock-infected controls.
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http://respiratory-research.com/content/14/1/91IFN-α [24]. The expression of IFN-α was shown to be re-
lated to the detection of self nucleic-acids that were
released due to the skin injury. Additionally, it was dem-
onstrated that pDC depletion significantly delayed wound
healing suggesting a functional role for these rare DC sub-
set in tissue repair. Alternatively, accumulation of pDC in
the post acute bacterial pneumonia phase may be related
to immunoregulatory functions of these cells. PDC have
the capacity to control both CD4+ and CD8+ T cell activa-
tion [39]. Antigen presentation to CD4 T cells via pDC
has been described to inhibit T helper 1 and T helper 17
immune responses, suggesting a possible role to prevent
T helper-dependent automimmunity [40]. In a different
study using a conditional plasmacytoid depletion model,
pDC were demonstrated to play an important role in the
stimulation of antiviral CD8+ T cell responses [41].
Our results indicate that Klebsiella pneumonia may
exhibit additionally inhibitory effects on DC. The ex vivo
analysis of MHC-class II expression on lung DC subsets
of Klebsiella pneumonia infected animals consistently in-
dicated decreased MHC-class II expression in compari-
son to mock-infected controls. This may be related to
the recruitement or differentiation of newly arrived DC.However, analysis of CCR7 migrating DC in the draining
MLN during infection additionally indicated decreased
MHC-class II expression suggesting Klebsiella pneumonia-
mediated suppression. Additionally, analysis of the inhibi-
tory molecule CD274 on lung DC during Klebsiella infec-
tion revealed a massive upregulation on CD11b DC and
MoDC and to a lesser extent on CD103 DC suggesting an-
other pathway of Klebsiella pneumonia-mediated suppres-
sion. Klebsiella-mediated induction of inhibitory molecule
CD274 on lung DC may be important in limiting antibac-
terial effector T cell responses and promoting infection-
associated immunosuppression [42,43]. In this context
it would be interesting to establish technologies allowing
precise DC subset specific enumeration of bacterial load.
Sorting strategies are limited due to a number of technical
factors, such as passive bacteria attachment, complex DC
phenotype, low DC frequency. Therefore, development of
other technologies, such as combination of specific staining
of bacterial-related gene products with DC subset markers
might be more successful [44].
Our results using ovalbumin-pulsed, Klebsiella pneumoniae-
stimulated purified pDC as stimulators of TCR transgenic
naive CD4+ T cells confirmed the finding, that pDC
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http://respiratory-research.com/content/14/1/91are not efficient CD4+ T cell stimulators. In direct
comparison to other respiratory DC subsets, Klebsiella
pneumonia-stimulated CD103+ DC and CD11b DC
represented the most efficient naïve CD4+ T cell activa-
tors. Moreover, MHC-class II and CD86 surface expres-
sion, representing important functional molecules
required for MHC-class II restricted CD4 activation
were markedly reduced on respiratory pDC from
Klebsiella-infected animals compared to either CD103+
DC and CD11b DC. Additionally, analysis of draining
MLN during infection revealed rapid relative and abso-
lute accumulation of CD103 DC, CD11b DC and
MoDC numbers within 48 h p.i. whereas pDC numbers
did exhibit only an absolute increase at d5 p.i. indicat-
ing a different role for T cell activation.
In summary, the present study has revealed marked
quantitative and qualitative differences for respiratory DC
subsets during sublethal respiratory Klebsiella pneumonia
infection. Both the in vivo as well as the in vitro data
underline the importance of differentiating respiratory DC
subsets during Klebsiella pneumonia. The analysis of lung
DC as a single cell population during infection would have
masked many of these differences. Our study highlights
that these lung subsets exhibit different migration kinetics,
different activatory/regulatory surface molecule expression
and different functional CD4 activatory capacity. With re-
spect to the novel finding of increased pDC during Klebsi-
ella infection, future studies are necessary to address the
functional role of pDC during bacterial pneumonia. The
use of in vivo DC subset depletion models in future stud-
ies will provide additional insight into the relevance of DC
subsets for CD4 and CD8 T effector cell expansion during
Klebsiella pneumonia infection.Additional files
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